Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Islet & Pancreas Transplant Articles

N.J. Hospital Teams With Ricordi to Find Cure for Type 1
Moms of Children with Diabetes Tell Their Stories, Ask to Support Research For a Cure
Pre-Diabetes Glossary
Should States Let Inmates Donate Organs?
Stem cells used to make pancreas, gut cells
Double Transplantation Treatment for Type 1 Diabetes
Academia, Biotech and the Pharmaceutical Industry Have Joined Forces to Fight Diabetes
Insulin-Producing Cells Derived from Specially Bred Pigs
Researchers Discover Protein that Triggers Islet Cell Rejection
Skin cells transformed directly into nerve cells: Are beta cells next?
Islet & Pancreas Transplant Archives
Browse the Islet & Pancreas Transplant Archives
Subscribe to the Research RSS Feed
Print | Email | Share | Comments (0)

New Way to Stimulate Your Pancreas


Feb 1, 1998

Prandin (repaglinide), a new type 2 oral medication manufactured by Novo Nordisk, has been approved by the FDA.

The new drug stimulates the secretion of insulin from the pancreas. It was created with a quick onset and short duration of action to be especially effective at mealtimes.

Bill Poole, president of Novo Nordisk, claims that Prandin helps "people with type 2 manage their diabetes at mealtimes. Prandin is a highly potent, fast-working agent that is absorbed rapidly after dosing and clears quickly from the bloodstream."

Prandin is expected to be available in the United States in the spring of this year.

Categories: Diabetes, Government & Policy, Insulin, Islet & Pancreas Transplant, Novo Nordisk, Type 2 Issues, Type 2 Medications

Donate to Diabetes Health

You May Also Be Interested In...

Comments

Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.